David Hoang
Stock Analyst at Deutsche Bank
(2.02)
# 3,132
Out of 5,044 analysts
46
Total ratings
38.89%
Success rate
-2.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Hoang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintains: Buy | $65 → $280 | $199.33 | +40.47% | 2 | Oct 17, 2025 | |
| SYRE Spyre Therapeutics | Initiates: Buy | $43 | $24.64 | +74.51% | 1 | Sep 26, 2025 | |
| HRMY Harmony Biosciences Holdings | Maintains: Buy | $54 → $36 | $29.64 | +21.46% | 4 | Sep 25, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Sell | $6 → $12 | $24.22 | -50.45% | 10 | Aug 15, 2025 | |
| ACAD ACADIA Pharmaceuticals | Upgrades: Buy | $20 → $35 | $22.62 | +54.73% | 5 | May 21, 2025 | |
| ALKS Alkermes | Maintains: Buy | $40 → $52 | $31.00 | +67.74% | 2 | Mar 27, 2025 | |
| XENE Xenon Pharmaceuticals | Initiates: Buy | $67 | $42.53 | +57.54% | 3 | Feb 11, 2025 | |
| DNLI Denali Therapeutics | Initiates: Buy | $31 | $16.92 | +83.22% | 3 | Feb 11, 2025 | |
| BHVN Biohaven | Initiates: Buy | $65 | $17.20 | +277.91% | 1 | Feb 11, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $176 | $133.51 | +31.83% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $18.59 | -35.45% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $150 → $158 | $147.38 | +7.21% | 4 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $2.29 | +205.68% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.92 | +170.27% | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.66 | +243.35% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $220 | $475.91 | -53.77% | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $80 | $39.55 | +102.28% | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $3 | $2.38 | +26.05% | 1 | Dec 7, 2022 |
Praxis Precision Medicines
Oct 17, 2025
Maintains: Buy
Price Target: $65 → $280
Current: $199.33
Upside: +40.47%
Spyre Therapeutics
Sep 26, 2025
Initiates: Buy
Price Target: $43
Current: $24.64
Upside: +74.51%
Harmony Biosciences Holdings
Sep 25, 2025
Maintains: Buy
Price Target: $54 → $36
Current: $29.64
Upside: +21.46%
Sarepta Therapeutics
Aug 15, 2025
Maintains: Sell
Price Target: $6 → $12
Current: $24.22
Upside: -50.45%
ACADIA Pharmaceuticals
May 21, 2025
Upgrades: Buy
Price Target: $20 → $35
Current: $22.62
Upside: +54.73%
Alkermes
Mar 27, 2025
Maintains: Buy
Price Target: $40 → $52
Current: $31.00
Upside: +67.74%
Xenon Pharmaceuticals
Feb 11, 2025
Initiates: Buy
Price Target: $67
Current: $42.53
Upside: +57.54%
Denali Therapeutics
Feb 11, 2025
Initiates: Buy
Price Target: $31
Current: $16.92
Upside: +83.22%
Biohaven
Feb 11, 2025
Initiates: Buy
Price Target: $65
Current: $17.20
Upside: +277.91%
Axsome Therapeutics
Feb 11, 2025
Initiates: Buy
Price Target: $176
Current: $133.51
Upside: +31.83%
Feb 11, 2025
Initiates: Buy
Price Target: $12
Current: $18.59
Upside: -35.45%
Aug 2, 2024
Maintains: Neutral
Price Target: $150 → $158
Current: $147.38
Upside: +7.21%
Jul 25, 2024
Initiates: Buy
Price Target: $7
Current: $2.29
Upside: +205.68%
Mar 15, 2024
Initiates: Buy
Price Target: $16
Current: $5.92
Upside: +170.27%
Mar 7, 2024
Initiates: Buy
Price Target: $16
Current: $4.66
Upside: +243.35%
Apr 26, 2023
Initiates: Neutral
Price Target: $220
Current: $475.91
Upside: -53.77%
Apr 26, 2023
Initiates: Outperform
Price Target: $80
Current: $39.55
Upside: +102.28%
Dec 7, 2022
Downgrades: Neutral
Price Target: $3
Current: $2.38
Upside: +26.05%